U.S. markets closed
  • S&P Futures

    3,838.00
    -10.50 (-0.27%)
     
  • Dow Futures

    30,782.00
    -86.00 (-0.28%)
     
  • Nasdaq Futures

    13,440.25
    -35.25 (-0.26%)
     
  • Russell 2000 Futures

    2,151.90
    -9.10 (-0.42%)
     
  • Crude Oil

    52.69
    -0.08 (-0.15%)
     
  • Gold

    1,857.80
    +2.60 (+0.14%)
     
  • Silver

    25.48
    -0.00 (-0.02%)
     
  • EUR/USD

    1.2146
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.0400
    -0.0510 (-4.67%)
     
  • Vix

    23.19
    +1.28 (+5.84%)
     
  • GBP/USD

    1.3673
    -0.0003 (-0.02%)
     
  • USD/JPY

    103.7140
    -0.0420 (-0.04%)
     
  • BTC-USD

    32,524.32
    +156.04 (+0.48%)
     
  • CMC Crypto 200

    657.63
    -19.27 (-2.85%)
     
  • FTSE 100

    6,638.85
    -56.22 (-0.84%)
     
  • Nikkei 225

    28,650.28
    -172.01 (-0.60%)
     

Weekly CEO Buys Highlight

GuruFocus.com

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

Cantel Medical

Cantel Medical Corp. (NYSE:CMD) President and CEO George L. Fotiades bought 5,000 shares on Jan. 16 at a price of $61.17. The price of the stock has increased by 10.33% since.

9c40d7ca1d02ea652460b00a3424afd6.png
9c40d7ca1d02ea652460b00a3424afd6.png


Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, including endoscope disinfection, water purification systems for use in dialysis treatment and disposable supplies in the dental office.

The company has a market cap of $2.87 billion. Its shares traded at $67.49 with a price-earnings ratio of 67.90 as of Jan. 24. Net income was $5.77 million for the first quarter of fiscal year 2020 compared to $19.24 million in the prior-year period.

Senior Vice President and General Counsel Jeffrey Z. Mann bought 750 shares on Jan. 23 at a price of $67.3. The price of the stock has increased by 0.28% since.

Director Mark N. Diker bought 2,000 shares on Jan. 17 at a price of $62.43. The price of the stock has increased by 8.11% since.

OPKO Health

OPKO Health Inc. (NASDAQ:OPK) CEO, Chairman and 10% Owner Phillip Frost bought 72,262 shares during the past week at the average price of $1.61.

a9b7c059c578c2bc508c87a4961bb1ab.png
a9b7c059c578c2bc508c87a4961bb1ab.png

OPKO Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. It has a development and commercial supply pharmaceutical company, a global supply-chain operation and holding company and a specialty active pharmaceutical ingredients manufacturer in Israel.

The company has a market cap of $1.05 billion. Its shares traded at $1.58 as of Jan. 24. Net loss for the third quarter of 2019 was $62.01 million compared to a net loss of $27.66 million in the prior-year quarter.

Frost bought 50,000 shares on Jan. 8 at a price of $1.47; 50,000 shares on Jan. 10 at a price of $1.48; 50,000 shares on Jan. 13 at a price of $1.44; 22,262 shares on Jan. 17 at a price of $1.56; and 50,000 shares on Jan. 23 at a price of $1.63. The price of the stock has decreased by 3.07% since.

For the complete list of stocks bought by their company CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial her

This article first appeared on GuruFocus.